跳至主要内容
临床试验/NCT06073366
NCT06073366招募中不适用

Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2013年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Recurrence

研究概览

简要总结

This observational study aims to establish a prospective nationwide cohort of venous thromboembolism. The main questions it mains to answer are:

  • Which patients with venous thromboembolism should accept long-term anticoagulation therapy?
  • Mechanism and prognosis of venous thromboembolism. Participants will receive yearly follow-ups through telephone, hospitalization, or outpatient care.

详细描述

Venous thromboembolism (VTE), including deep venous thrombosis and pulmonary embolism, is a class of diseases with strong occultation, high mortality, and a high recurrence rate.Long-term anticoagulant therapy can reduce the risk of recurrence. Although long-term anticoagulation can reduce the risk of VTE recurrence, it will also increase the risk of major bleeding and the economic burden of long-term anticoagulation. Therefore, stratifying the risk of VTE recurrence and preventing recurrence with accurate anticoagulant therapy is an urgent problem in VTE management.

Investigators will establish a prospective nationwide cohort of VTE, develop a unified follow-up plan, and conduct whole-life follow-up management for patients. Demographic, clinical, imaging, laboratory indicators, gene, and other information of patients will be collected. A VTE patient database with complete clinical phenotype data, genetic data, and biological samples will be established.

Investigators will construct a VTE recurrence risk prediction model based on Chinese data to provide clinical decision suggestions for clinicians to select appropriate individualized anticoagulant duration according to risk stratification. VTE patients with low recurrence risk could avoid long-term anticoagulant therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater or equal to
  • Patients diagnosed with venous thromboembolism.

排除标准

  • Pregnant or lactating women
  • Patients with active tumor

结局指标

主要结局

Recurrence

时间窗: through study completion, an average of 1 year

recurrence of venous thromboembolism

次要结局

  • Bleeding episode(through study completion, an average of 1 year)
  • All-cause death(through study completion, an average of 1 year)

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Lu Hua

Chief Physician

China National Center for Cardiovascular Diseases

研究点 (1)

Loading locations...

相似试验